Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 12, 2004, Pages 6185-6192

  Coutant, Régis ^a   De Casson, Florence Boux ^a   Rouleau, Stéphanie ^a   Douay, Olivier ^a   Mathieu, Elisabeth ^a   Gatelais, Frédérique ^a   Bouhours Nouet, Natacha ^a   Voinot, Christelle ^a   Audran, Maurice ^a,b   Limal, Jean Marie ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; HUMAN GROWTH HORMONE; INSULIN; MOXOMAT; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADOLESCENCE; ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; COMPARATIVE STUDY; CORRELATION ANALYSIS; DELAYED PUBERTY; DRUG EFFECT; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GROWTH RATE; HORMONE RELEASE; HUMAN; HYPOGLYCEMIA; MALE; NORMAL HUMAN; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADOLESCENT DEVELOPMENT; BODY COMPOSITION; BODY HEIGHT; CHILD; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PUBERTY; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 10344243495     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0814     Document Type: Article

References (53)

1. Veldhuis JD 1996 Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 134:287-295
2. Veldhuis JD, Roemmich JN, Rogol AD 2000 Gender and sexual maturation-dependent contrasts in the neuroregulation of growth hormone secretion in prepubertal and late adolescent males and females - a general clinical research center-based study. J Clin Endocrinol Metab 85:2385-2394
3. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sonksen PH 2000 The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab 85:4193-4200
4. Drake WM, Howell SJ, Monson JP, Shalet SM 2001 Optimizing GH therapy in adults and children. Endocr Rev 22:425-450
5. Span JP, Pieters GF, Sweep CG, Hermus AR, Smals AG 2000 Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J Clin Endocrinol Metab 85:1121-1125
6. Parkinson C, Ryder WD, Trainer PJ 2001 The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab 86:5240-5244
7. Weissberger AJ, Ho KK, Lazarus L 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381
8. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR 1996 Effects of oral versus transdermal estrogen on the growth hormone/ insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 81:2848-2853
9. Cook DM, Ludlam WH, Cook MB 1999 Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 84:3956-3960
10. Bellantoni MF, Harman SM, Cho DE, Blackman MR 1991 Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J Clin Endocrinol Metab 72:172-178
11. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thomer MO 1996 Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - a clinical research center study. J Clin Endocrinol Metab 81:2250-2256
12. Helle SI, Omsjo IH, Hughes SC, Botta L, Huls G, Holly JM, Lonning PE 1996 Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. Clin Endocrinol (Oxf) 45:727-732
13. Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z 1992 Transdermal 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest 15:533-538
14. Lissett CA, Shalet SM 2003 The impact of dose and route of estrogen administration on the somatotropic axis in normal women. J Clin Endocrinol Metab 88:4668-4672
15. Janssen YJ, Helmerhorst F, Frolich M, Roelfsema F 2000 A switch from oral (2 mg/day) to transdermal (50 microg/day) 17β-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab 85:464-467
16. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA 1993 Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab 77:776-779
17. Grumbach MM, Styne DM 2003 Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Larsen PR, Kronenberg HM, Melmed S, Polonski KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders; 1115-1286
18. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
19. Marshall WA, Tanner JM 1969 Variations in the pattern of pubertal changes in girls. Arch Dis Child 44:291-303
20. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-24
21. Usher R, McLean F 1969 Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants bom between 25 and 44 weeks of gestation. J Pediatr 74:901-910
22. Sempé M, Pedron G, Roy-Pernot MP 1979 Auxologie, méthodes et séquences. Paris: Théraplix Public
23. Rolland-Cachera MT, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A 1991 Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 45:13-21
24. Reiter EW, Rosenfeld RG 2003 Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S, Polonski KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders; 1003-1114
25. Zar J 1984 Measures of dispersion and variability. In: Zar J, ed. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ. Prentice-Hall; 27-39
26. Streiner DL, Norman GR 1995 Reliability. In: Streiner DL, Norman GR, eds. Health measurement scales: a practical guide to their development and use. 2nd ed. New York: Oxford University Press; 104-127
27. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752
28. Martha Jr PM, Rogol AD, Veldhuis JD, Kerrigan JR, Goodman DW, Blizzard RM 1989 Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys. J Clin Endocrinol Metab 69:563-570
29. Aguiar-Oliveira MH, Gill MS, de A Baretto ES, Alcantara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE 1999 Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J Clin Endocrinol Metab 84:4118-4126
30. Maheshwari HG, Silverman BL, Dupuis J, Baumann G 1998 Phenotypic and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J Clin Endocrinol Metab 83:4065-4074
31. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Fielder PJ 1990 The little women of Loja-growth hormone-receptor deficiency in an inbred population of southern Ecuador. N Engl J Med 323:1367-1374
32. Jorge AA, Souza SC, Arnhold IJ, Mendonca BB 2004 The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: suppression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration. Clin Endocrinol (Oxf) 60:36-40
33. Murphy LJ, Friesen HG 1988 Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology 122:325-332
34. Phillip M, Palese T, Hernandez ER, Roberts Jr CT, LeRoith D, Kowarski AA 1992 Effect of testosterone on insulin-like growth factor-I (IGF-I) and IGF-I receptor gene expression in the hypophysectomized rat. Endocrinology 130:2865-2870
35. Mauras N, O'Brien KO, Klein KO, Hayes V 2000 Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab 85:2370-2377
36. Eakman GD, Dallas JS, Ponder SW, Keenan BS 1996 The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab 81:1217-1223
37. Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minute F, Giordano G, Delitala G, Camanni F 1999 Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol 276:E1009-E1013
38. Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M 1998 Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83:382-395
39. Martha Jr PM, Reiter EO, Davila N, Shaw MA, Holcombe JH, Baumann G 1992 The role of body mass in the response to growth hormone therapy. J Clin Endocrinol Metab 75:1470-1473
40. Hanaire-Broutin H, Sallerin-Caute B, Poncet MF, Tauber M, Bastide R, Chale JJ, Rosenfeld R, Tauber JP 1996 Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM. Diabetologia 39:1498-1504
41. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KKY 2000 Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab 85:4712-4720
42. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
43. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092
44. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324-7329
45. Kriström B, Jansson C, Rosberg S, Albertsson-Wikland K 1997 Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. J Clin Endocrinol Metab 82:2889-2898
46. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG 2002 Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety. J Clin Endocrinol Metab 87:90-98
47. Lee PD, Durham SK, Martinez V, Vasconez O, Powell DR, Guevara-Aguirre J 1997 Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab 82:2266-2274
48. Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG 2001 The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab 86:5176-5183
49. Blair JC, Camacho-Hubner C, Miraki Moud F, Rosberg S, Burren C, Lim S, Clayton PE, Bjarnason R, Albertsson-Wikland K, Savage MO 2004 Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature. Clin Endocrinol (Oxf) 60:161-168
50. Buckway CK, Selva KA, Pratt KL, Tjoeng E, Guevara-Aguirre J, Rosenfeld RG 2002 Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity. J Clin Endocrinol Metab 87:4754-4765
51. Carel JC, Tresca JP, Letrait M, Chaussain JL, Lebouc Y, Job JC, Coste J 1997 Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab 82:2117-2121
52. Jorge AA, Souza SC, Arnhold IJ, Mendonca BB 2002 Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene. J Clin Endocrinol Metab 87:469-472
53. Goddard AD, Covello R, Luoh SM, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LM 1995 Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. N Engl J Med 333:1093-1098